title: Postprandial hyperglycemia is associated with an increase of blood pressure in type 1 diabetic patients treated with continuous subcutaneous insulin infusion.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Lepore
authors.forename: Anna
authors.initials: A
authors.lastname: Corsi
authors.forename: Alessandro R
authors.initials: AR
authors.lastname: Dodesini
authors.forename: Italo
authors.initials: I
authors.lastname: Nosari
authors.forename: Roberto
authors.initials: R
authors.lastname: Trevisan
mesh_terms: D000328:Adult; D001794:Blood Pressure / Q000502:physiology*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D006943:Hyperglycemia / Q000209:etiology / Q000503:physiopathology*; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage; D008875:Middle Aged; D019518:Postprandial Period
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin